Turbo Elite
Payments companies reported to CMS as associated with Turbo Elite. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Turbo Elite, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Turbo Elite
These are the largest totals companies reported as associated with Turbo Elite. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Inder Singh | Sacramento, CA | Interventional Cardiology | $269.04 |
| Ibrahim Ali | Manhasset, NY | Interventional Cardiology | $140.65 |
| Lawrence Goldstein | Napa, CA | Vascular Surgery | $97.22 |
| Lindsey Korepta | Charleston, SC | Vascular Surgery | $61.33 |
| Sanjay Wunnava | Tampa, FL | $41.41 | |
| Rajiv Nagesetty | Walnut Creek, CA | Vascular Surgery | $40.07 |
| Brian Keyashian | Walnut Creek, CA | Vascular Surgery | $40.06 |
| Nicolas Wozmak | Napa, CA | Anesthesiology | $37.40 |
| Jose Suarez | Lubbock, TX | Interventional Cardiology | $33.41 |
| John Lee | Oakland, NJ | Interventional Cardiology | $32.66 |
Prescribed Turbo Elite?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.